SIRT7 and breast carcinoma: We recently demonstrated that SIRT7 deficiency activates TGF-β signaling, enhances EMT and promotes lung metastasis [24], and induces mesenchymal-like CSCs marked with CD44+CD24- in breast cancers (Figure S1), providing a proof of concept of aging-promoted CSC induction.